Gene · 4830
Papers3,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of immune signatures in Parkinson's disease based on co-expression networks. | Front Genet | 2023 | 36733342 | PubTator, text mining | PubMed |
| Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy. | Nat Commun | 2023 | 36732507 | PubTator, text mining | PubMed |
| KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers? | Cancer Metastasis Rev | 2023 | 36720764 | PubTator, text mining | PubMed |
| Identification of prognostic and predictive biomarkers in high-dimensional data with PPLasso. | BMC Bioinformatics | 2023 | 36690931 | PubTator, text mining | PubMed |
| Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance. | Mol Cancer | 2023 | 36681803 | PubTator, text mining | PubMed |
| Time-resolved RNA signatures of CD4+ T cells in Parkinson's disease. | Cell Death Discov | 2023 | 36681665 | PubTator, text mining | PubMed |
| Molecular Aspects and Therapeutic Implications of Herbal Compounds Targeting Different Types of Cancer. | Molecules | 2023 | 36677808 | PubTator, text mining | PubMed |
| C1QBP Mediates Breast Cancer Cell Proliferation and Growth via Multiple Potential Signalling Pathways. | Int J Mol Sci | 2023 | 36674861 | PubTator, text mining | PubMed |
| The genomic regulation of metastatic dormancy. | Cancer Metastasis Rev | 2023 | 36600151 | PubTator, text mining | PubMed |
| The Landmark Series: Intraductal Papillary Mucinous Neoplasms of the Pancreas-From Prevalence to Early Cancer Detection. | Ann Surg Oncol | 2023 | 36600097 | PubTator, text mining | PubMed |
| Oncoprotein SET dynamically regulates cellular stress response through nucleocytoplasmic transport in breast cancer. | Cell Biol Toxicol | 2023 | 36534342 | PubTator, text mining | PubMed |
| Phosphohistidine signaling promotes FAK-RB1 interaction and growth factor-independent proliferation of esophageal squamous cell carcinoma. | Oncogene | 2023 | 36513743 | PubTator, text mining | PubMed |
| Structure-function analyses of coiled-coil immune receptors define a hydrophobic module for improving plant virus resistance. | J Exp Bot | 2023 | 36472617 | PubTator, text mining | PubMed |
| Nanobody-peptide-conjugate (NPC) for passive immunotherapy against SARS-CoV-2 variants of concern (VoC): a prospective pan-coronavirus therapeutics. | Mol Divers | 2023 | 36400898 | PubTator, text mining | PubMed |
| Orthologous genes Pm12 and Pm21 from two wild relatives of wheat show evolutionary conservation but divergent powdery mildew resistance. | Plant Commun | 2023 | 36352792 | PubTator, text mining | PubMed |
| Pharmacogenetics of ABCB1, CDA, DCK, GSTT1, GSTM1 and outcomes in a cohort of pediatric acute myeloid leukemia patients from Colombia. | Cancer Rep (Hoboken) | 2023 | 36316809 | PubTator, text mining | PubMed |
| Force tuning through regulation of clathrin-dependent integrin endocytosis. | J Cell Biol | 2023 | 36250940 | PubTator, text mining | PubMed |
| HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36244648 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Sevoflurane but not propofol enhances ovarian cancer cell biology through regulating cellular metabolic and signaling mechanisms. | Cell Biol Toxicol | 2023 | 36207479 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4830/papers?page=13